Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Guardian System by TurnCare has been implemented to prevent sacral region blood flow impairment in critical care settings. It has reportedly helped thousands of patients by reducing adverse events such as hospital-acquired pressure injuries and improving patient management for clinicians. The company’s solutions are commercially available and have demonstrated improved outcomes in high-acuity patient populations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TurnCare.